69616-290Level 3
Fycompa (perampanel)
**Product type:** Human Prescription Drug
**Active ingredient:** PERAMPANEL
**Strength:** .5 mg/mL
**Dosage form:** Suspension
**Route:** Oral
**Labeler:** Catalyst Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA208277)
**Pharmacologic class:** AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
**DEA schedule:** CIII
GET
/api/v1/systems/ndc_fda/nodes/69616-290Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.